A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. Early detection of PC is the ...
The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing ...
Oncolytics (ONCY) reported on progress in 2025 with key regulatory and clinical advancements, reinforcing pelareorep’s potential in ...
2h
The most well-known symptoms are bloating and pelvic pain, but there are more 'under-the-radar' symptoms to watch out for, ...
With federal support, universities produce world-changing discoveries and the next generation of exquisitely well-trained ...
Toni Bravo thought she was having an anxiety attack a couple weeks before finals at the University of Notre Dame last year.
Luminescent gold nanoparticles (L-AuNPs) represent a novel class of luminescent nanomaterials that have attracted ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback